Abdullah Feroze is a neurosurgical resident at Seattle Children's Hospital who wants to cure pediatric brain tumors. While at Stanford, he pioneered the use of monoclonal antibody vaccine to block the CD47 signal that cancer cells express. The process is currently being used in clinical trials for different subtypes of leukemias and brain tumors. In 2019, he was named a Forbes 30 Under 30 honoree in healthcare.

Healthcare, Healthcare Quality & Safety, Healthcare Providers Cancer, Medicine, Health, Technology, Science, Research & Exploration, Research Scientist,